- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imaging chain pulls out of bankruptcy
Medical Resources has closed the book on Chapter 11—and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the
Medical Resources has closed the book on Chapter 11-and slammed the door on many of its shareholders. As part of the financial restructuring, holders of $75 million in senior notes will receive approximately 84% of its common stock, with the remaining equity distributed to other creditors and plaintiffs in lawsuits. PreChapter 11 shareholders will receive no distributions, and their shares of common stock will be canceled. With fewer than 300 record holders of its common stock, the company is no longer subject to the reporting requirements of the Securities Exchange Act of 1934. Medical Resources, which owns 70 imaging centers, marked completion of the restructuring by acquiring new MRI and CT scanners for its Springfield (PA) Diagnostic Imaging Center and Sarasota (FL) Outpatient affiliates.
New AI-Powered Ultrasound Devices May Enhance Efficiency in Women's Imaging
April 19th 2024One of the features on the new Voluson Signature 20 and 18 ultrasound devices reportedly uses automated AI tools to facilitate a 40 percent reduction in the time it takes to perform second trimester exams.
FDA Approves Fluorescence Imaging System for Detecting Residual Breast Cancer
April 18th 2024The combination of the optical imaging agent Lumisight and the fluorescence imaging device Lumicell Direct Visualization System, collectively known as LumiSystem, reportedly offers 84 percent accuracy with real-time detection of residual breast cancer after lumpectomy procedures.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.
